Antidepressant fluvoxamine reduces long COVID fatigue in clinical trial
A randomized placebo-controlled trial found that fluvoxamine, a low-cost antidepressant, reduced fatigue and improved quality of life in adults with long COVID, offering one of the first evidence-based medication options…